Φορτώνει......
P01.10 METABOLIC CONDITIONS DETERMINE SENSITIVITY OF GLIOMA CELLS AGAINST EPIDERMAL-GROWTH FACTOR RECEPTOR (EGFR)-INHIBITION
The epidermal growth factor (EGFR) pathway is a frequently activated oncogenic pathway in glioblastoma. Nevertheless, the clinical results using EGFR inhibitors in glioma therapy are disappoiting. The reasons for the failure of these inhibitors are unclear but may involve factors of the tumor microe...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , , , , , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Oxford University Press
2014
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4185443/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou174.103 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|